China’s pharma innovators pursue a range of deal structures to support global expansion

Thanks to its scientific skills base, growing prowess in AI and a policy environment that supports rapid clinical trials, China has become one of the world’s leading markets for pharmaceutical innovation. Here we explore how the country’s pharma businesses are expanding internationally via out-licensing, partnership and NewCo deals—and the key legal and regulatory angles involved in these diverse transaction structures.... By: A&O Shearman